Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Alfredo O. Donoso is active.

Publication


Featured researches published by Alfredo O. Donoso.


Neuroendocrinology | 1992

Restraining Action of GABA on Estradiol-Induced LH Surge in the Rat: GABA Activity in Brain Nuclei and Effects of GABA Mimetics in the Medial Preoptic Nucleus

Alicia Seltzer; Alfredo O. Donoso

The relationship between GABA dynamics and LH release was studied on day 2 after subcutaneous estrogen implant in short-term ovariectomized rats. GABA accumulation, used as an index of GABA turnover, was determined in the medial preoptic nucleus (MPN), medial (MS) and lateral (LS) septal nuclei, median eminence-mediobasal hypothalamus (MBH) and locus ceruleus (LC). Measurements of GABA were performed at two different times of day (11.00 and 15.00 h), 3 h after intraperitoneal administration of gamma-vinyl-GABA (GVG), an irreversible inhibitor of GABA transaminase. Either morning or afternoon ovariectomized rats (OVX) showed a significant increase in GABA accumulation after GVG treatment in all the areas studied. Estrogen-treated OVX rats showed in the morning a lower GABA accumulation in the MPN, MBH and LC, and GABA levels remained unchanged in the LS and MS. In the afternoon, the MPN and LS showed a lower rate of GABA accumulation whereas in the MBH and LC the GABA increase was not observed. In contrast the MS showed a rate of GABA accumulation similar as in the OVX rats. Local administration in the MPN of 20 micrograms GVG, or GABA-A receptor stimulation by muscimol (50 ng), prior to the increase in plasma LH levels, prevented the occurrence of the estradiol-induced LH surge. The effect of muscimol was reversed by bicuculline (30 ng), a GABA-A receptor antagonist. Bicuculline in low doses lacked effect by itself. In conclusion, these results strongly suggest that a decreased GABAergic activity in MPN, MBH and LC precedes the estradiol-evoked LH surges in ovariectomized rats. Moreover, that in septal nuclei, a low GABAergic activity takes place well before the occurrence of plasma LH increase.(ABSTRACT TRUNCATED AT 250 WORDS)


Psychopharmacology | 1979

Effects of a histamine synthesis inhibitor and antihistamines on the sexual behavior of female rats

Alfredo O. Donoso; Susana T. Broitman

Intraventricular administration of α-hydrazinohistidine, a histamine synthesis inhibitor, at different doses and times before testing produced a significant decrease of lordotic responses and sexual receptivity in ovariectomized estrogen plus progesterone-primed female rats. The H1-antihistamines pyrilamine and chlorfeniramine and the H2-antihistamine metiamide, injected in the lateral ventricle, significantly decreased the lordosis quotient but did not modify receptivity; antihistamine-injected rats showed no soliciting behavior. Exploratory activity was decreased by both α-hydrazinohistidine and metiamide but not by the H1-antihistamines. It is concluded that treatments which either deplete histamine or block their receptors can alter female copulatory responsiveness. The mechanism of this antihistamine effect appears to be unrelated to that of other side effects, such as motor impairment, sedation, or local anesthesia.


Physiology & Behavior | 1986

Restraint stress stimulation of prolactin and ACTH secretion: role of brain histamine

Alicia Seltzer; Alfredo O. Donoso; E. Podestá

The possible role of brain histamine in the release of prolactin, ACTH and corticosterone following acute restraint, was pharmacologically evaluated in adult male rats. Fifteen min of restraint caused marked increases in the plasma levels of these hormones. alpha-Fluoromethyl histidine (FH), a histidine decarboxylase inhibitor which depleted hypothalamic histamine, inhibited the enhancement of plasma prolactin levels. In contrast, plasma ACTH levels were not modified. FH treatment decreased plasma corticosterone concentrations in animals submitted to stress or in rest; this suggests a direct action of FH on the adrenal. Intraventricular (IVT) injection of ranitidine (H2 antagonist) blunted the prolactin response to restraint stress whereas its systemic administration had no effect. On the contrary, pyrilamine (H1 antagonist) given systemically decreased slightly, but significantly, the prolactin rise but when injected IVT it was ineffective. Pyrilamine was also unable to affect the ranitidine action. ACTH and corticosterone levels in plasma of restrained rats were not modified by the histamine antagonists. It is concluded that histamine is involved, mainly through central H2 receptors, in the enhancement of plasma prolactin levels produced by an acute stress. The failure of both antihistaminic compounds and a histamine depletor to alter the ACTH stimulation suggest that histamine has no participation in the hypophysio-corticoadrenal response to acute restraint.


Psychopharmacology | 1978

Effects of chronic imipramine and clomipramine oral administration on maternal behavior and litter development

Susana T. Broitman; Alfredo O. Donoso

The effects of the oral administration of imipramine (IM) or clomipramine (CIM) in adult female rats before pregnancy or during nursing were evaluated. IM caused a significant decrease of body weight in both groups of animals and affected the body weight of litters when administered during nursing. CIM reduced the increase of weight in the mothers throughout the experiment. Both IM and CIM decreased water and food intake and locomotor activity of the adult rats. Rats treated during nursing with IM showed decreased maternal behavior at various times of treatment. The milk intake of pups from drug-treated mothers also decreased. Pup eyeopening was delayed by CIM both before pregnancy and during nursing and by IM treatment during nursing. Vaginal opening was retarded in female litters from mothers treated during nursing. Openfield behavior showed modifications at 60 days of age in male pups from mothers exposed to IM during nursing.Results indicate that the two tricyclic drugs were able to produce general and behavioral modifications in both mothers and their litters. These modifications seem to depend on whether the drug is given before pregnancy or during nursing. Control experiments in dams fed with a restricted diet suggest that the observed alterations in maternal behavior and litter development is not due to the undernourishment caused by drug administration.


Neuroendocrinology | 1980

H1- and H2-Histamine Receptor Antagonists and Induced Release of Prolactin in Male Rats

Alfredo O. Donoso; A.M. Banzán

The effects of 3rd ventricle injection of metiamide, an H2-histamine receptor antagonist and pyrilamine, an H1-histamine receptor antagonist, on the increase of plasma prolactin induced by two doses of histamine in normal male rats were studied. Metiamide did prevent the stimulating action of histamine whereas pyrilamine was not effective. Histamine-induced prolactin release was also blocked by low doses of the 2 antihistamines given in combination. Metiamide per se has no effect but high doses of pyrilamine increased plasma prolactin levels and augmented the hormone response to histamine. The results suggest mediation of H2-receptors in the facilitatory action of histamine on prolactin release.


Physiology & Behavior | 1995

Interaction between glutamate and luteinizing hormone-releasing hormone (LHRH) in lordosis behavior and luteinizing hormone release (LH): Further studies on NMDA receptor mediation

Pascual A. Gargiulo; Alfredo O. Donoso

The present studies examine the effects of the glutamate agonist N-Methyl-D-Aspartic acid on lordosis responsiveness and LH release in estrogen-primed, ovariectomized rats. Groups of rats previously cannulated in the 3rd ventricle of the brain (IVT) were challenged with saline, NMDA and LHRH. A clear increase in lordosis-to-mount quotients (LQ) after IVT administration of 0.5, 0.75 and 1 microgram NMDA was found. LHRH (150 ng IVT) also enhanced LQ. High plasma LH levels were present in both cases. Intraventricular administration of the selective LHRH antagonist [D-p-Glu1, D-Phe2, D-Trp3,6]-LHRH (100 ng) was unable to prevent NMDA action on lordosis behavior. In contrast, it blunted LHRH enhancement of LQ. LH release evoked by either NMDA and LHRH was blocked by the LHRH antagonist. Present results support our previous view suggesting that glutamate, through NMDA receptors, participates in the regulation of lordosis behavior. Glutamate seems to exert its actions in the behavioral and endocrine patterns through different mechanisms; the first seems not to be mediated by LHRH, but the endocrine effect operates via LHRH release.


Neuroendocrinology | 1974

Further evidence on the direct action of L-Dopa on prolactin release.

Alfredo O. Donoso; A.M. Banzán; J.C. Barcaglioni

Male rats with anterior pituitary transplants underneath the kidney capsule were injected with L-dopa (20 mg/kg i.v.). Plasma prolactin levels which were high in these animals fell as early as 10 min


Neuroendocrinology | 1988

Localized Increase of GABA Levels in Brain Areas of the Rat and Inhibition of the Plasma LH Rise following Orchidectomy

Alfredo O. Donoso

Previous studies have suggested that gamma-aminobutyric acid (GABA) exerts inhibitory actions on luteinizing hormone (LH) secretion that are likely to be mediated by modifications in noradrenergic transmission. To explore further this hypothesis we have studied the effect of increasing GABA contents in discrete areas of the brain on plasma LH levels in short-term orchidectomized rats. GABA accumulation was produced by the GABA transaminase inhibitor, gamma-vinyl-GABA (GVG). The locus coeruleus area (LC), where the noradrenaline (NA) cells projecting through the dorsal noradrenergic bundle are located, and several hypothalamic areas that are innervated by NA-containing fibers were microinjected with GVG. Most of these areas are known to be related to the neural control of LH secretion. GVG microinjected in the LC and medial preoptic area increased the GABA content and blunted significantly the acute increase of plasma LH produced by castration. Bicuculline prevented these effects. Delayed effects of GVG were observed when applied in the anterior hypothalamic area and ventromedial-arcuate nucleus area. In these latter areas, a single injection of GVG did not augment the GABA concentrations and was unable to prevent LH release, but a clear inhibitory effect took place after a second injection of GVG between 24 and 48 h after orchidectomy. Unresponsive areas to GVG treatment were the lateral preoptic area, the median eminence and the dorsal raphe. These results add support to the view that GABA inhibits LH release in rats, at discrete areas of the brain.


European Journal of Pharmacology | 1998

NMDA receptor antagonists block stress-induced prolactin release in female rats at estrus

Claudia Bregonzio; Carlos E. Navarro; Alfredo O. Donoso

In order to evaluate the role of glutamate in prolactin secretion, we examined the effects of N-methyl-D,L-aspartic acid (NMDA) receptor antagonists on serum prolactin levels at both resting and restraint-stress conditions in female rats at estrus. NMDA increased basal serum prolactin levels. Administration of the selective NMDA receptor antagonist, cis-4-phosphonomethyl-2-piperidine carboxylic acid (CGS 19755) (5 and 10 mg/kg i.p.), to rats under resting conditions enhanced basal prolactin levels. A low dose of CGS 19755 (3 mg/kg) was unable to modify the hormone serum level. Under stress conditions the pretreatment with CGS 19755 (3 and 5 mg/kg) prevented the increase in serum prolactin levels. This effect was reversed by NMDA (60 mg/kg s.c.). The NMDA receptor antagonist (5 mg/kg) decreased the median eminence concentration of the dopamine metabolite, 3,4-dihydroxyphenylacetic acid (DOPAC), without modifying dopamine content. To examine the probable link between serotonin (5-HT) and glutamate in prolactin release, the 5-HT2A/5-HT2C receptor antagonist, ritanserin, was used. Under resting conditions, a dose of 5 mg/kg s.c. blocked the NMDA-induced prolactin release. In rats submitted to restraint, ritanserin decreased the prolactin response and NMDA was unable to correct the stress serum prolactin levels. The 5-HT1A receptor agonist, 8-hidroxypropyl-amino tetralin (8-OH-DPAT) (3 mg/kg s.c.), increased basal serum prolactin levels and restored serum prolactin in stressed animals pretreated with CGS 19755 (5 mg/kg). The present data strongly suggest that the glutamatergic system participates in the regulation of prolactin secretion. A stimulation tone seems to be exerted via the tuberoinfundibular dopaminergic system, and the prolactin release evoked by restraint apparently involves glutamate/NMDA receptors linked to a serotoninergic pathway.


Brain Research Bulletin | 1995

Interaction between glutamate and GABA on 3H-noradrenaline release from rat hypothalamus

Carlos E. Navarro; Ricardo J. Cabrera; Alfredo O. Donoso

Glutamate has been shown to stimulate noradrenaline (NA) release from hypothalamic nerve terminals. In the present study, we evaluated the possible interaction between the excitatory amino acid glutamate and gamma-aminobutyric acid (GABA), an inhibitory transmitter, on noradrenaline (NA) release from mediobasal hypothalamus (MBH) of adult male rats. Hypothalamic slices loaded in vitro with 3H-NA were superfused and exposed to glutamate, N-methyl-D-aspartic acid (NMDA), or kainate (KA). We found that 3H-NA release evoked by the excitatory amino acids glutamate and NMDA was dramatically decreased by GABA. The facilitatory effects of NMDA and KA were prevented concentration-dependently by the GABAB receptor antagonist 2-hydroxy saclofen which restored the NMDA effect. In addition, baclofen blocked K(+)-induced 3H-NA release. Activation of GABAA receptors by muscimol and THIP was ineffective. In conclusion, glutamate and GABA, through GABAB receptors, may interact to modulate NA release from the rat mediobasal hypothalamus.

Collaboration


Dive into the Alfredo O. Donoso's collaboration.

Top Co-Authors

Avatar

Alicia Seltzer

Facultad de Ciencias Médicas

View shared research outputs
Top Co-Authors

Avatar

Susana T. Broitman

Facultad de Ciencias Médicas

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Carlos E. Navarro

Facultad de Ciencias Médicas

View shared research outputs
Top Co-Authors

Avatar

Mirtha B. Zárate

Facultad de Ciencias Médicas

View shared research outputs
Top Co-Authors

Avatar

A.M. Banzán

Facultad de Ciencias Médicas

View shared research outputs
Top Co-Authors

Avatar

Arturo M. Banzan

Facultad de Ciencias Médicas

View shared research outputs
Top Co-Authors

Avatar

Claudia Bregonzio

Facultad de Ciencias Médicas

View shared research outputs
Top Co-Authors

Avatar

Ricardo J. Cabrera

Facultad de Ciencias Médicas

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge